PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review
Physician-scientists at Groupe de Recherche Action en Santé (GRAS) in Burkina Faso have successfully completed initial safety evaluations in 30 adult Burkinabés as the first phase of a clinical trial…